The impact of the COVID-19 pandemic on time to treatment in head and neck cancer management: a systematic review
Acta Oncologica,
Journal Year:
2025,
Volume and Issue:
64, P. 156 - 166
Published: Jan. 28, 2025
Background
and
purpose:
Coronavirus
disease
2019
(COVID-19)
caused
a
need
for
reorganization
in
the
healthcare
systems.
First,
we
aimed
to
determine
impact
of
COVID-19
pandemic
on
time
treatment
head
neck
cancer
(HNC)
patients.
Second,
tumor
stage
changes
regimens
used.
Material
methods:
A
systematic
search
PubMed
Embase
was
conducted
according
Preferred
Reporting
Items
Systematic
Reviews
Meta-Analyses
guidelines.
Inclusion
criteria
were:
(1)
Studies
including
patients
with
squamous
cell
carcinomas;
(2)
containing
comparison
treatment;
(3)
well-defined
interval
restrictions
health
care
due
without
restrictions.
Results:
total
19
studies
were
included
comprising
24,898
treated
HNC
cancer.
Six
(10.1%
patients)
reported
an
increase
waiting
within
at
least
one
interval,
while
seven
decrease
(83.2%
patients),
six
found
no
significant
effect.
No
modalities
observed.
Seven
15
(12.7%
observed
either
overall
stage,
size,
or
node
metastasis
classification
during
pandemic.
Among
these,
two
increased
times
as
well.
Interpretation:
The
COIVD-19
heterogenous
subject
considerable
intercountry
interregional
variations.
tendency
toward
higher
T-classification
In
conclusion,
otorhinolaryngology
departments
demonstrated
resilience,
led
only
slight
alterations
treatment.
Language: Английский
Análisis de la supervivencia de los pacientes con tumores malignos de cabeza y cuello diagnosticados durante la pandemia de COVID-19
Acta Otorrinolaringológica Española,
Journal Year:
2025,
Volume and Issue:
76(2), P. 106 - 115
Published: Feb. 16, 2025
Impact of the Sars-COVID-19 Pandemic on the “Early Diagnosis” of Laryngeal Tumors: Data From Monocentric Tertiary Care Hospital of South Italy
Journal of Voice,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 1, 2024
Language: Английский
Time to treatment for head and neck cancer patients decreased during the early phase of the Covid-19 pandemic
Jason Tasoulas,
No information about this author
Gabrielle-Jaquelline Adams,
No information about this author
Travis P. Schrank
No information about this author
et al.
Oral Oncology,
Journal Year:
2024,
Volume and Issue:
155, P. 106879 - 106879
Published: June 8, 2024
Language: Английский
Impact of the COVID-19 pandemic on the diagnosis and treatment of patients with head and neck cancer in Brandenburg and Berlin
J. Carré,
No information about this author
Beatrice Herzog,
No information about this author
Daniela Reil
No information about this author
et al.
HNO,
Journal Year:
2023,
Volume and Issue:
72(2), P. 90 - 101
Published: Dec. 20, 2023
Factors affecting laryngectomy rate during the COVID-19 pandemic
Olivia Elkington,
No information about this author
Heidi Webb,
No information about this author
Jonathan Woliansky
No information about this author
et al.
Australian Journal of Otolaryngology,
Journal Year:
2024,
Volume and Issue:
8, P. 1 - 1
Published: Nov. 6, 2024
Language: Английский
Einfluss der Corona-Pandemie auf Diagnostik und Therapie von Kopf-Hals-Tumoren
Benjamin Prokein,
No information about this author
Michael Dau,
No information about this author
Bernhard Frerich
No information about this author
et al.
HNO,
Journal Year:
2024,
Volume and Issue:
72(12), P. 893 - 899
Published: Nov. 6, 2024
Zusammenfassung
Hintergrund
Nach
Auftreten
der
ersten
COVID-19-Fälle
hatte
sich
das
Virus
innerhalb
weniger
Monate
weltweit
verbreitet.
Hierbei
zeigte
ein
Rückgang
an
ärztlichen
Konsultationen.
Die
vorliegende
Studie
untersucht,
ob
dies
Auswirkungen
auf
die
Diagnose
und
Therapie
von
Kopf-Hals-Tumorerkrankungen
–
bezogen
den
Zeitraum
2018
bis
2022.
Material
Methode
Kopf-Hals-Tumordaten
des
Klinischen
Krebsregisters
(KKR)
Mecklenburg-Vorpommern
aus
dem
2020–2022
wurden
beiden
Vorjahren
(2018,
2019)
gegenübergestellt.
Erfasst
demografische
Daten,
Fallzahlen,
Daten
zu
Diagnose,
ICD
TNM-Klassifikation.
vom
Robert
Koch-Institut
(RKI)
abgefragt.
mittels
Mann-Whitney-U-Test
Korrelation
nach
Pearson
analysiert.
Ergebnisse
Insgesamt
konnten
2332
Patientenfälle
in
eingeschlossen
werden.
Im
Rahmen
Lockdowns
weder
signifikanter
Tumormeldungen
KKR
noch
eine
signifikante
zwischen
COVID-19-Fallzahlen
Tumordiagnosen.
Signifikante
Unterschiede
zeigten
T‑Kategorie
im
Jahr
2022
Prä-COVID-19-Jahren
2019.
Außerdem
wurde
Verschiebung
relativen
Häufigkeiten
einzelnen
ICD-10-Codes
beobachtet.
Schlussfolgerung
COVID-19-Pandemie
keine
signifikanten
beim
Vergleich
Jahre
Entgegen
Erwartungen
eines
Rückgangs
Fallzahlen
Pandemie
durch
Lockdown
mit
Erhöhung
Tumorstadien
konnte
sogar
Reduktion
gefunden
werden
sowie
einzelner
über
Pandemie.